Virginia F Borges Selected Research

Neoplasm Metastasis (Metastasis)

10/2022	Replicative Instability Drives Cancer Progression.
11/2020	Extracellular vesicles from young women's breast cancer patients drive increased invasion of non-malignant cells via the Focal Adhesion Kinase pathway: a proteomic approach.
1/2019	A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma.
1/2019	Association Between Postpartum Breast Cancer Diagnosis and Metastasis and the Clinical Features Underlying Risk.
1/2017	Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases.
9/2014	Cyclooxygenase-2-dependent lymphangiogenesis promotes nodal metastasis of postpartum breast cancer.
6/2013	Genomic signatures of pregnancy-associated breast cancer epithelia and stroma and their regulation by estrogens and progesterone.
6/2009	Hepatic complications of breast cancer.
6/2009	Pregnancy and breast cancer: when they collide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Virginia F Borges Research Topics

Disease

79	Breast Neoplasms (Breast Cancer) 06/2023 - 01/2003
54	Neoplasms (Cancer) 04/2024 - 11/2002
9	Neoplasm Metastasis (Metastasis) 10/2022 - 06/2009
6	Brain Neoplasms (Brain Tumor) 12/2021 - 07/2014
4	Triple Negative Breast Neoplasms 01/2021 - 01/2018
4	Melanoma (Melanoma, Malignant) 01/2019 - 03/2013
4	Disease Progression 10/2018 - 01/2009
3	Noninfiltrating Intraductal Carcinoma (DCIS) 12/2022 - 08/2011
2	Amenorrhea 07/2021 - 08/2014
2	Diarrhea 01/2018 - 07/2017
1	Central Nervous System Diseases (CNS Diseases) 06/2023
1	Chronic Disease (Chronic Diseases) 03/2023
1	Cognitive Dysfunction 11/2022
1	Carcinoma (Carcinomatosis) 10/2022
1	Vitamin D Deficiency 01/2021
1	Dyspareunia 12/2020
1	Musculoskeletal Pain 01/2019

Drug/Important Bio-Agent (IBA)

19	Hormones (Hormone)IBA 05/2023 - 04/2005
14	Estrogen ReceptorsIBA 04/2024 - 12/2008
7	Estrogens (Estrogen)FDA Link 01/2018 - 12/2008
6	tucatinibIBA 06/2023 - 07/2017
6	Trastuzumab (Herceptin)FDA Link 01/2023 - 01/2003
6	Phenobarbital (Luminal)FDA Link 01/2022 - 07/2015
6	Biomarkers (Surrogate Marker)IBA 01/2020 - 12/2008
5	Aromatase InhibitorsIBA 06/2023 - 04/2005
5	CollagenIBA 04/2023 - 08/2011
5	Tamoxifen FDA LinkGeneric 01/2013 - 04/2005
4	Fulvestrant (Faslodex)FDA Link 05/2023 - 04/2005
3	ErbB Receptors (EGF Receptor)IBA 01/2022 - 07/2014
3	pertuzumabIBA 06/2021 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 11/2020 - 01/2009
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2020 - 08/2011
3	Semaphorins (Semaphorin)IBA 01/2020 - 11/2018
3	CytokinesIBA 01/2019 - 04/2015
3	human ERBB2 proteinIBA 01/2018 - 01/2003
3	Ado-Trastuzumab EmtansineIBA 01/2018 - 07/2014
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2014 - 08/2011
3	4-azidobenzylcarazolol (pABC)IBA 06/2013 - 06/2009
3	exemestane (Aromasin)FDA Link 12/2008 - 04/2005
2	palbociclibIBA 06/2023 - 01/2022
2	Cyclin D1IBA 06/2023 - 01/2022
2	Letrozole (Femara)FDA LinkGeneric 06/2023 - 04/2005
2	Fibrillar CollagensIBA 01/2022 - 08/2011
2	Immune Checkpoint InhibitorsIBA 01/2021 - 10/2018
2	Phosphotransferases (Kinase)IBA 09/2019 - 01/2018
2	Estradiol (Delestrogen)FDA LinkGeneric 01/2019 - 01/2013
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2019 - 12/2017
2	Progesterone FDA LinkGeneric 01/2018 - 06/2013
2	taxaneIBA 01/2018 - 01/2009
2	AntigensIBA 01/2016 - 11/2002
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 09/2014 - 04/2014
2	AnthracyclinesIBA 01/2009 - 01/2003
2	Estrogen Receptor Modulators (Antiestrogen)IBA 12/2008 - 04/2005
1	AndrogensIBA 05/2023
1	enzalutamideIBA 05/2023
1	Collagen Type III (Type III Collagen)IBA 04/2023
1	HydrogelsIBA 04/2023
1	Gonadal Steroid Hormones (Sex Hormones)IBA 03/2023
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2022
1	neratinibIBA 06/2021
1	atezolizumabIBA 01/2021
1	BenzodiazepinesIBA 01/2021
1	Vitamin D FDA LinkGeneric 01/2021
1	Opioid Analgesics (Opioids)IBA 01/2021
1	pembrolizumabIBA 01/2021
1	Nucleic AcidsIBA 11/2020
1	Focal Adhesion Protein-Tyrosine KinasesIBA 11/2020
1	ProteomeIBA 11/2020
1	Fibronectins (Fibronectin)IBA 01/2020
1	p21-Activated KinasesIBA 09/2019
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 09/2019
1	Aurora Kinase AIBA 09/2019
1	MLN 8237IBA 09/2019
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019
1	EnzymesIBA 01/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	tropomyosin kinaseIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Tryptophan (L-Tryptophan)FDA Link 01/2019
1	Interleukin-8 (Interleukin 8)IBA 01/2019
1	KynurenineIBA 01/2019
1	Conditioned Culture MediaIBA 01/2019
1	IpilimumabIBA 10/2018
1	Ibuprofen (Motrin)FDA LinkGeneric 10/2018

Therapy/Procedure

32	Therapeutics 06/2023 - 01/2003
13	Drug Therapy (Chemotherapy) 01/2023 - 01/2003
5	Immunotherapy 01/2021 - 03/2013
4	Segmental Mastectomy (Lumpectomy) 04/2024 - 08/2009
4	Mastectomy (Mammectomy) 12/2022 - 11/2015
3	Neoadjuvant Therapy 01/2022 - 01/2018
3	Radiotherapy 10/2021 - 07/2014
3	Adjuvant Chemotherapy 02/2021 - 10/2016
3	Chemoprevention 12/2016 - 07/2013
2	Prophylactic Mastectomy 12/2022 - 11/2015
2	Aftercare (After-Treatment) 11/2020 - 01/2018
1	Mammaplasty (Breast Reconstruction) 10/2021
1	Continuity of Patient Care 01/2021
1	Ovariectomy (Oophorectomy) 01/2019